1
Hummel, B., Harskamp, R.E., Bolijn, R., Moll van Charante, E. P., Galenkamp, H., Mommersteeg, P.M.C., van Valkengoed, I. G. M.
Veröffentlicht in: Hummel , B , Harskamp , R E , Bolijn , R , Moll van Charante , E P , Galenkamp , H , Mommersteeg , P M C & van Valkengoed , I G M 2023 , ' Psychosocial factors may serve as additional eligibility criteria for cardiovascular risk screening in women and men in a multi-ethnic population : The HELIUS study ' , Preventive Medicine , vol. 172 , 107515 . https://doi.org/10.1016/j.ypmed.2023.107515;
2023
Veröffentlicht in: Hummel , B , Harskamp , R E , Bolijn , R , Moll van Charante , E P , Galenkamp , H , Mommersteeg , P M C & van Valkengoed , I G M 2023 , ' Psychosocial factors may serve as additional eligibility criteria for cardiovascular risk screening in women and men in a multi-ethnic population : The HELIUS study ' , Preventive Medicine , vol. 172 , 107515 . https://doi.org/10.1016/j.ypmed.2023.107515;
2023
2
3
Castelijns, MC, Helmink, MAG, Hageman, SHJ, Asselbergs, FW, de Borst, GJ, Bots, ML, Cramer, MJ, Dorresteijn, JAN, Emmelot-Vonk, MH, Geerlings, MI, de Jong, PA, van der Kaaij, NP, Kappelle, LJ, Lely, AT, van der Meer, MG, Mol, BM, Nathoe, HM, Onland-Moret, NC, van Petersen, RB, Ruigrok, YM, van Smeden, M, Teraa, M, Vandersteen, A, Verhaar, MC, Westerink, J, Visseren, FLJ
2023
2023
4
Eikendal, ALM, Groenewegen, KA, Anderson, TJ, Britton, AR, Engstrom, G, Evans, GW, de Graaf, J, Grobbee, DE, Hedblad, B, Holewijn, S, Ikeda, A, Kitagawa, K, Kitamura, A, Lonn, EM, Lorenz, MW, Mathiesen, EB, Nijpels, G, Dekker, JM, Okazaki, S, O'Leary, DH, Polak, JF, Price, JF, Robertson, C, Rembold, CM, Rosvall, M, Rundek, T, Salonen, JT, Sitzer, M, Stehouwer, CDA, Hoefer, IE, Peters, SAE, Bots, ML, den Ruijter, HM
2015
2015
5
6
7
8
9
de Vries, Folgerdiena M., Denig, Petra, Visser, Sipke T., Hak, Eelko, Postma, Maarten J.
Veröffentlicht in: de Vries , F M , Denig , P , Visser , S T , Hak , E & Postma , M J 2014 , ' Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands ' , Value in Health , vol. 17 , no. 2 , pp. 223-230 . https://doi.org/10.1016/j.jval.2013.12.010;
2014
Veröffentlicht in: de Vries , F M , Denig , P , Visser , S T , Hak , E & Postma , M J 2014 , ' Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands ' , Value in Health , vol. 17 , no. 2 , pp. 223-230 . https://doi.org/10.1016/j.jval.2013.12.010;
2014
10